202 related articles for article (PubMed ID: 19535570)
1. Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats.
Schaier M; Vorwalder S; Sommerer C; Dikow R; Hug F; Gross ML; Waldherr R; Zeier M
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F769-80. PubMed ID: 19535570
[TBL] [Abstract][Full Text] [Related]
2. FTY720 attenuates tubulointerstitial inflammation and fibrosis in subtotally nephrectomized rats.
Ni HF; Chen JF; Zhang MH; Pan MM; Zhang JD; Liu H; Tang RN; Ma KL; Liu BC
Ren Fail; 2013 Aug; 35(7):996-1004. PubMed ID: 23848241
[TBL] [Abstract][Full Text] [Related]
3. The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy.
Krämer S; Binder E; Loof T; Wang-Rosenke Y; Martini S; Khadzhynov D; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2009 Jul; 297(1):F218-27. PubMed ID: 19439518
[TBL] [Abstract][Full Text] [Related]
4. FTY720 reduces extracellular matrix expansion associated with ischemia-reperfusion induced injury.
Delbridge MS; Shrestha BM; Raftery AT; El Nahas AM; Haylor J
Transplant Proc; 2007 Dec; 39(10):2992-6. PubMed ID: 18089307
[TBL] [Abstract][Full Text] [Related]
5. FTY720 inhibits tubulointerstitial inflammation in albumin overload-induced nephropathy of rats via the Sphk1 pathway.
Xu M; Liu D; Ding LH; Ma KL; Wu M; Lv LL; Wen Y; Liu H; Tang RN; Liu BC
Acta Pharmacol Sin; 2014 Dec; 35(12):1537-45. PubMed ID: 25399649
[TBL] [Abstract][Full Text] [Related]
6. Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis.
Peters H; Martini S; Wang Y; Shimizu F; Kawachi H; Krämer S; Neumayer HH
Kidney Int; 2004 Oct; 66(4):1434-43. PubMed ID: 15458436
[TBL] [Abstract][Full Text] [Related]
7. FTY720, a synthetic sphingosine 1 phosphate analogue, inhibits development of atherosclerosis in low-density lipoprotein receptor-deficient mice.
Nofer JR; Bot M; Brodde M; Taylor PJ; Salm P; Brinkmann V; van Berkel T; Assmann G; Biessen EA
Circulation; 2007 Jan; 115(4):501-8. PubMed ID: 17242282
[TBL] [Abstract][Full Text] [Related]
8. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
Chiba K; Matsuyuki H; Maeda Y; Sugahara K
Cell Mol Immunol; 2006 Feb; 3(1):11-9. PubMed ID: 16549044
[TBL] [Abstract][Full Text] [Related]
9. Pirfenidone inhibits macrophage infiltration in 5/6 nephrectomized rats.
Chen JF; Ni HF; Pan MM; Liu H; Xu M; Zhang MH; Liu BC
Am J Physiol Renal Physiol; 2013 Mar; 304(6):F676-85. PubMed ID: 23152296
[TBL] [Abstract][Full Text] [Related]
10. FTY720 ameliorates experimental autoimmune neuritis by inhibition of lymphocyte and monocyte infiltration into peripheral nerves.
Zhang Z; Zhang ZY; Fauser U; Schluesener HJ
Exp Neurol; 2008 Apr; 210(2):681-90. PubMed ID: 18261728
[TBL] [Abstract][Full Text] [Related]
11. FTY720 prevents progression of renal fibrosis by inhibiting renal microvasculature endothelial dysfunction in a rat model of chronic kidney disease.
Ni H; Chen J; Pan M; Zhang M; Zhang J; Chen P; Liu B
J Mol Histol; 2013 Dec; 44(6):693-703. PubMed ID: 23907620
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor ameliorates renal interstitial inflammation in rat remnant kidney by modulating tubular expression of macrophage chemoattractant protein-1 and RANTES.
Gong R; Rifai A; Tolbert EM; Biswas P; Centracchio JN; Dworkin LD
J Am Soc Nephrol; 2004 Nov; 15(11):2868-81. PubMed ID: 15504940
[TBL] [Abstract][Full Text] [Related]
13. S1P modulator FTY720 limits matrix expansion in acute anti-thy1 mesangioproliferative glomerulonephritis.
Martini S; Krämer S; Loof T; Wang-Rosenke Y; Daig U; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1761-70. PubMed ID: 17356129
[TBL] [Abstract][Full Text] [Related]
14. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
Ciechanowicz A
Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
[TBL] [Abstract][Full Text] [Related]
15. Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury.
Ko GJ; Boo CS; Jo SK; Cho WY; Kim HK
Nephrol Dial Transplant; 2008 Mar; 23(3):842-52. PubMed ID: 17984109
[TBL] [Abstract][Full Text] [Related]
16. Reduction of ischemia-reperfusion injury in the rat kidney by FTY720, a synthetic derivative of sphingosine.
Delbridge MS; Shrestha BM; Raftery AT; El Nahas AM; Haylor JL
Transplantation; 2007 Jul; 84(2):187-95. PubMed ID: 17667810
[TBL] [Abstract][Full Text] [Related]
17. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
Chiba K
Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
[TBL] [Abstract][Full Text] [Related]
18. Different protective actions of losartan and tempol on the renal inflammatory response to acute sodium overload.
Rosón MI; Della Penna SL; Cao G; Gorzalczany S; Pandolfo M; Toblli JE; Fernández BE
J Cell Physiol; 2010 Jul; 224(1):41-8. PubMed ID: 20232302
[TBL] [Abstract][Full Text] [Related]
19. Effect of FTY720 on chronic cyclosporine nephropathy in rats.
Kim JY; Lim SW; Li C; Kim JS; Ahn KO; Yang HJ; Choi BS; Kim YS; Kim J; Bang BK; Yang CW
Transplantation; 2005 Nov; 80(9):1323-30. PubMed ID: 16314802
[TBL] [Abstract][Full Text] [Related]
20. Cytoprotective Actions of FTY720 Modulate Severe Preservation Reperfusion Injury in Rat Renal Transplants.
Fuller TF; Hoff U; Kong L; Naether M; Wagner P; Nieminen-Kelhä M; Nolting J; Luft FC; Hegner B; Dragun D
Transplantation; 2010 Feb; 89(4):402-8. PubMed ID: 20177341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
